-
GTA 6 Release Date Confirmed for November 19; Troubleshooting Pre-load and Launch Errors
-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Dolphin Congratulates Shore Fire Media and Its Clients on 20 GRAMMY(R) Nominations, Including 10 Best Album Nods Across Diverse Genres
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Dermata Announces U.S. Trademark Registration for TOME(R)
-
Olenox October Bitcoin Production Climbs to Three-Month High as Uptime and Hashrate Advance
-
5E Advanced Materials Highlights Commercial Momentum in First Month as an Operating Borates Producer
-
Trout CPA Expands Partner Leadership with Michael Carr and Dan Lerew
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
Jumia Reports Third Quarter 2026 Results
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
What to Do When Two Households Become One
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
TrizCom PR Wins Fourth PRSA Dallas Best of Show Award; Founder Jo Trizila Receives Norm Teich Award
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
'Not based on science': US confronts abortion 'reversal' myths
Wracked by guilt after taking an abortion pill, a sobbing woman calls a US hotline. It recommends a "reversal" treatment to save the fetus -- despite medical warnings that it is potentially life-threatening.
Misinformation about medical termination appears to have skyrocketed since last June, when the Supreme Court overturned the landmark 1973 Roe v. Wade decision that guaranteed a constitutional right to abortion.
That includes false "pro-life" posts on social media claiming abortion pills cause cancer and infertility -- as well as "pro-choice" content promoting dubious herbal treatments to terminate a pregnancy.
More striking, researchers say, is a wave of misleading content that promotes an unscientific treatment that promises to undo the effects of the first pill, mifepristone, in the two-drug regimen for medical abortion.
Anti-abortion advocates in the United States have heralded the so-called "reversal" treatment -- which involves taking the hormone progesterone -- for women who change their minds after taking mifepristone.
"Abortion pill reversal can help turn back the clock," reads the website for the Abortion Pill Rescue Network (APRN), a pro-life outfit that supports the treatment.
"When destructive voices would only say 'it is done,' abortion pill reversal says 'here is a second chance at life, just in time.'"
APRN's website lists anecdotal "success stories" -- emotional testimonies from women who opted for the treatment. Some, including a single mother identified as Shashana, broke down after taking the first pill, consumed with regret.
She reached out to APRN's hotline that got her started on the "reversal" procedure that her written testimony says saved her fetus.
What is not mentioned is the warning from the American College of Obstetrics and Gynecologists (ACOG), an association of reproductive health specialists, that calls the treatment "unproven," "unethical" and "not based on science."
Also omitted is a 2019 medical trial by researchers from the University of California, Davis, to test the effectiveness of the "reversal" treatment. The trial had to be stopped prematurely after some participants experienced severe internal bleeding.
- 'Potential to harm' -
"The anecdotal 'success stories' often fail to acknowledge that there is no reputable medical evidence that taking progesterone to reverse the effects of mifepristone increases the likelihood of a pregnancy continuing," Anicka Slachta, a senior analyst at the watchdog NewsGuard, told AFP.
"Ultimately, omitting that context and presenting abortion pill 'reversal' as definitively safe and effective has the potential to cause harm."
When AFP requested APRN provide supporting data and interviews with the women cited under the "success stories," a publicist for Heartbeat International, an anti-abortion group that backs the network, replied.
She inquired what AFP's article intended to highlight but stopped responding thereafter.
When a US health misinformation researcher reached APRN's hotline posing as a pregnant woman, she was told the network had successfully saved 4,000 babies through the "reversal" treatment.
The hotline operator did not reveal the number of unsuccessful cases but mentioned a success rate of 64-68 percent, a statistic also cited on the network's website.
When the researcher -- who shared the audio recording with AFP -- pointed out that ACOG did not consider the treatment as safe, the operator dismissed the organization as "very pro-abortion," a stance that makes them "biased."
The operator said a prayer that she "make the right decision" -– that is, not carry out the abortion.
- 'Bodily autonomy' -
"What was clear in the call is that this group cares more about the life of the baby than the mother, point blank," the researcher told AFP, requesting anonymity for fear of online harassment.
"That was evident in the way they referred to the fetus but also through the omission of any real data about the risks."
In a report last week, the Center for Countering Digital Hate (CCDH) said thousands of "fake clinics" across the United States -- which seek to prevent "abortion-determined" people from accessing care -- collectively spent $10.2 million on Google search ads over the past two years.
Many of them, it said, promoted the "potentially dangerous" reversal procedure.
Research by the technology nonprofit Meedan Digital Health Lab shows that in the months after Roe v. Wade was overturned, online conversations about pill "reversals" were among three topics associated with abortion misinformation that saw a dramatic surge.
"It's not the idea of someone changing their mind on their own about having an abortion that's dangerous," Jenna Sherman, a program manager at the nonprofit, told AFP.
"It's pushing an unverified and potentially life-threatening intervention in an effort to be anti-abortion first and foremost over everything, rather than support people's bodily autonomy."
J.Gomez--AT